ChIP experiments in mouse AML cells have demonstrated binding of C/EBPβ to sequences corresponding to the promoter region of one of the human GFI1 transcript variants [28] (www.ncbi.nlm.nih.gov/genome/gdv/browser/geo/?id=GSE66122). The gene discussed is CEBPB; the disease is acute myeloid leukemia.